← Medication Database
Other Specialties

Menveo

Generic: MenACWY-CRM conjugate meningococcal 2-55 years

Manufacturer: GlaxoSmithKline Biologicals  ·  Program: GSK Patient Assistance Program

Apply for Assistance

Eligibility Criteria

Insurance Requirement

Eligible patients who do not have insurance or whose insurance does not cover the GSK product; availability varies by product

Residency

US resident

Eligibility varies by product; for uninsured or underinsured patients lacking coverage

Program Information

Processing Time

2–8 weeks

Delivery Method

shipped to patient or physician office

Application Method

Multiple

Reauthorization

Required — annual

Typically Required Documents

ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.

  • proof of income
  • proof of residency
  • prescription
  • proof of insurance status

Indicated For

Invasive meningococcal disease (serogroups A, C, Y, W-135)

About This Medication

# GSK Patient Assistance Program Patient Guide: How to Get Menveo at Low or No Cost ## About This Program The **GSK Patient Assistance Program** is a charitable program managed by the GSK Patient Access Programs Foundation, an independent 501(c)(3) nonprofit organization. This program helps eligible patients receive **Menveo (MenACWY-CRM)**, a meningococcal vaccine, at **no cost** if they cannot afford it through traditional insurance or out-of-pocket payment. ## About Menveo **Menveo** is a meningococcal conjugate vaccine indicated for active immunization to prevent invasive meningococcal disease caused by *Neisseria meningitidis* serogroups A, C, Y, and W-135 in individuals 2 months through 55 years of age.[3] The vaccine does not prevent serogroup B infections.[3] Menveo is available in two formulations: a two-vial presentation requiring reconstitution (approved for ages 2 months through 55 years) and a one-vial liquid formulation (approved for ages 10 through 55 years).[4] ## Who Qualifies for This Program? You may be eligible for the GSK Patient Assistance Program if you meet these criteria: - **Uninsured**: You do not have health insurance coverage - **Underinsured**: Your insurance does not cover Menveo or your coverage is insufficient - **Financial need**: You lack the financial resources to pay for the vaccine out-of-pocket - **U.S. resident**: You reside in the United States Eligibility varies by specific GSK product, so confirmation of Menveo eligibility is required during the application process. ## Income Eligibility The program does not publish specific income thresholds; instead, eligibility is determined on a case-by-case basis. The program evaluates your financial situation holistically, considering: - Household income - Family size - Current expenses and financial obligations - Insurance status and coverage gaps If you are uncertain whether your income qualifies, you are encouraged to apply. Program staff will review your circumstances during the application process. ## Insurance Requirements You are eligible if: - You have **no health insurance** (uninsured) - Your **current insurance does not cover Menveo** - Your insurance coverage is **insufficient** to make the vaccine affordable **Important note**: Some patient assistance programs exclude Medicare enrollees. However, the GSK program may have different rules. Contact the program directly to confirm whether you are eligible if you are enrolled in Medicare. ## Required Documentation When you apply, be prepared to provide: 1. **Proof of income**: Recent pay stubs, tax returns, or benefit statements (Social Security, unemployment, etc.) 2. **Proof of residency**: Utility bill, lease agreement, or government-issued ID with current address 3. **Prescription**: A valid prescription for Menveo from your healthcare provider 4. **Proof of insurance status**: Insurance card (if applicable), denial letter from your insurance, or documentation showing you are uninsured ## How to Apply Follow these steps to apply for the GSK Patient Assistance Program: ### Step 1: Gather Your Documents Collect the required documentation listed above before starting your application. ### Step 2: Contact the Program Reach out to the GSK Patient Assistance Program through one of these methods: - **Visit the GSK website**: Go to gskforyou.com/programs/patient-assistance-program/ for online application options - **Call for assistance**: Contact the GSK Help Center for phone-based support and to request an application - **Work with your healthcare provider**: Your doctor's office may be able to submit the application on your behalf ### Step 3: Complete the Application Provide all requested information and documentation. Be thorough and accurate to avoid delays. ### Step 4: Submit Your Application Submit your completed application along with supporting documents through the method indicated by the program (online portal, mail, fax, or through your provider). ### Step 5: Await Approval The program will review your application and contact you with a decision. ## Timeline and Delivery **Processing time**: The program does not publicly specify how long approval takes. Processing times may vary based on application completeness and volume. Contact the program for an estimate. **Delivery method**: Once approved, Menveo will be **shipped directly to you or to your healthcare provider's office**. Your healthcare provider will administer the vaccine during an office visit. ## What If Your Application Is Denied? If your application is denied, you have several alternatives: 1. **Request reconsideration**: Ask the program to review your application if your circumstances have changed or if you believe additional information supports your eligibility 2. **Explore other assistance programs**: Other organizations may offer vaccine assistance; ask your healthcare provider for referrals 3. **Contact your local health department**: Many county and state health departments offer free or low-cost vaccines to uninsured and underinsured residents 4. **Discuss payment plans**: Ask your healthcare provider or pharmacy about payment plan options 5. **Look into community health centers**: Federally qualified health centers (FQHCs) often provide vaccines on a sliding fee scale based on income ## Reauthorization If you need additional doses of Menveo (such as a booster dose), **reauthorization is required**. You will need to reapply or request renewal through the program. Contact the GSK Patient Assistance Program to initiate the reauthorization process. ## Important Disclaimers - This guide provides general information about the GSK Patient Assistance Program. Specific eligibility requirements, documentation needs, and processes may vary. - The program is subject to change at any time. For the most current information, visit gskforyou.com or contact the GSK Help Center directly. - This program is separate from government insurance programs (Medicare, Medicaid) and does not replace them. - Approval is not guaranteed. Eligibility is determined on a case-by-case basis. - If you are enrolled in Medicare, confirm your eligibility with the program before applying, as some patient assistance programs have restrictions for Medicare beneficiaries. ## Contact Information For questions or to apply: - **Website**: gskforyou.com/programs/patient-assistance-program/ - **GSK Help Center**: Visit the website for customer service support and contact information - **Your healthcare provider**: Ask your doctor's office for assistance with the application process --- *This guide is intended for informational purposes only and does not constitute medical advice. Always consult with your healthcare provider about vaccination recommendations and eligibility for assistance programs.*

Program information last verified: March 30, 2026

Ready to apply for Menveo assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications